On International Day of Rural Women, we recognize the challenges women in remote and underserved communities around the world face in accessing health services for themselves and their families. It’s especially important to recognize those barriers while also continuing to propel ourselves and our partners forward in delivering unique solutions to help overcome them.
As Pfizer celebrates 15 years of skills-based volunteering through its Global Health Fellows and Teams volunteer programs, which deploy colleagues around the world to work with international development organization partners through long- and short-term assignments, a team member reflects on the impact the program had on his life.
Abbott delivers shared value across Africa by finding unique ways to expand access to innovative rapid testing technologies.
Blog
Despite health improvements made across Africa in recent years, significant health challenges remain for 1.2 billion people living across the continent. The region shoulders some of the world's heaviest infectious disease burdens: 90 percent of the world’s malaria cases and nearly 70 percent of the 36.7 million HIV cases worldwide. Adding further complication, healthcare access for those living in rural sub-Saharan Africa is limited.
Antibiotics are a key component in the global effort to eliminate trachoma, the world’s leading infectious cause of blindness. One of several neglected tropical diseases (NTDs) the World Health Organization (WHO) has identified for elimination, trachoma is a preventable disease, and one that affects those living in communities with limited access to healthcare, clean water and sanitation.
At Pfizer, we strive to improve the health and well-being of individuals around the world and in doing so, we are proud to help support several of the United Nations Sustainable Development Goals (SDGs). Our commitment to advancing the SDGs is rooted in our belief that every individual deserves to live a longer, healthier and more productive life.
We should be investing in disadvantaged communities in the same way we invest in our own families
Summary:
Jacob Lief is the Founder and CEO of Ubuntu Pathways (formerly Ubuntu Education Fund), a nonprofit organization that takes vulnerable children in Port Elizabeth, South Africa from cradle to career. The organization was recognized as an honoree for the 2018 Lipman Family Prize, a social impact initiative from the Wharton School of Business at the University of Pennsylvania.
Blog
Jacob Lief is the Founder and CEO of Ubuntu Pathways (formerly Ubuntu Education Fund), a nonprofit organization that takes vulnerable children in Port Elizabeth, South Africa from cradle to career. The organization was recognized as an honoree for the 2018 Lipman Family Prize, a social impact initiative from the Wharton School of Business at the University of Pennsylvania.
July 19, 2018 /3BL Media/ - For the third year in a row, The Dow Chemical Company (Dow) will send top professionals into the field as Global Health Corporate Champions (GHCC), to work with local organizations to improve health in Africa.
Neglected tropical diseases (NTDs) affect over one billion people worldwide. This group of viral, bacterial and parasitic diseases can be found in 149 countries – that’s 76 percent of countries in the world – and most often affects impoverished populations, who lack access to clean water or sanitation and live in close contact with infectious vectors. The effects of NTDs on communities can be devastating – keeping children out of school and preventing adults from going to work or caring for themselves or their families.
In today’s increasingly complex world, businesses – and the visionary leaders behind them – are playing an important role in catalyzing the new, innovative and inclusive approaches needed to solve pressing global challenges and create more equitable, just and healthy communities.
Pfizer has long been a partner in the global effort to eliminate trachoma, the world’s leading infectious cause of blindness, through its donation of an oral antibiotic that can help treat and prevent the debilitating disease. Now, Pfizer has announced that it will extend its donation of the antibiotic through 2025, building on the company’s 20-year support of a partnership to eliminate this disease.
